Virtu Financial LLC Makes New Investment in Agilent Technologies, Inc. $A

Virtu Financial LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,842 shares of the medical research company’s stock, valued at approximately $2,836,000.

A number of other hedge funds also recently made changes to their positions in the stock. Gabelli Funds LLC grew its holdings in shares of Agilent Technologies by 1.1% during the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after purchasing an additional 74 shares during the last quarter. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC boosted its position in Agilent Technologies by 1.6% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares in the last quarter. Freestone Capital Holdings LLC boosted its position in Agilent Technologies by 2.0% in the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after buying an additional 84 shares in the last quarter. Finally, Grove Bank & Trust boosted its position in Agilent Technologies by 5.5% in the fourth quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock valued at $239,000 after buying an additional 92 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages have recently issued reports on A. Robert W. Baird upped their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Royal Bank Of Canada initiated coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Barclays boosted their price objective on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Finally, Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $160.93.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $127.49 on Friday. The business has a 50-day moving average price of $121.28 and a two-hundred day moving average price of $126.92. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a market cap of $36.01 billion, a P/E ratio of 25.60, a PEG ratio of 2.21 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the business earned $1.31 EPS. The firm’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.